Prometheus Site 22 is a clinical research site located in Great Neck, New York, United States 11021.
Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.
Prometheus Site 22 has participated in 1 clinical trials.
Therapeutic areas: Ulcerative Colitis.
Sponsors: Prometheus Laboratories.
Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Prometheus Site 22 has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Prometheus Site 22 has 1 clinical trials on record. Their work covers Ulcerative Colitis.
Prometheus Site 22 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.